BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22299829)

  • 1. Lipocalin-type prostaglandin D synthase as a marker for the proliferative potential of melanocyte-lineage cells in the human skin.
    Shimanuki M; Takeda K; Kawaguchi M; Suzuki T; Shibahara S
    J Dermatol; 2012 Aug; 39(8):699-704. PubMed ID: 22299829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-type prostaglandin D synthase as a regulator of the retinoic acid signalling in melanocytes.
    Takeda K; Takahashi NH; Yoshizawa M; Shibahara S
    J Biochem; 2010 Aug; 148(2):139-48. PubMed ID: 20403807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
    Takeda K; Yokoyama S; Aburatani H; Masuda T; Han F; Yoshizawa M; Yamaki N; Yamamoto H; Eguchi N; Urade Y; Shibahara S
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1098-106. PubMed ID: 16337607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids.
    Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Exp Cell Res; 2012 Feb; 318(4):408-15. PubMed ID: 22100987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells.
    Lange C; Brunswig-Spickenheier B; Eissing L; Scheja L
    Exp Cell Res; 2012 Nov; 318(18):2284-96. PubMed ID: 22698646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of prostaglandin D(2) production through cyclooxygenase-2 and lipocalin-type prostaglandin D synthase by upstream stimulatory factor 1 in human brain-derived TE671 cells under serum starvation.
    Fujimori K; Aritake K; Urade Y
    Gene; 2008 Dec; 426(1-2):72-80. PubMed ID: 18817855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.
    Fujimori K; Fukuhara A; Inui T; Allhorn M
    J Neurochem; 2012 Jan; 120(2):279-91. PubMed ID: 22043816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes.
    Chowdhury AA; Hossain MS; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Biochem Biophys Res Commun; 2011 Jul; 411(2):287-92. PubMed ID: 21726533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compact packing of lipocalin-type prostaglandin D synthase induced by binding of lipophilic ligands.
    Inoue K; Yagi N; Urade Y; Inui T
    J Biochem; 2009 Feb; 145(2):169-75. PubMed ID: 19015161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish and chicken lipocalin-type prostaglandin D synthase homologues: Conservation of mammalian gene structure and binding ability for lipophilic molecules, and difference in expression profile and enzyme activity.
    Fujimori K; Inui T; Uodome N; Kadoyama K; Aritake K; Urade Y
    Gene; 2006 Jun; 375():14-25. PubMed ID: 16616995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin-type prostaglandin D synthase protects against oxidative stress-induced neuronal cell death.
    Fukuhara A; Yamada M; Fujimori K; Miyamoto Y; Kusumoto T; Nakajima H; Inui T
    Biochem J; 2012 Apr; 443(1):75-84. PubMed ID: 22248185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of lipocalin-type prostaglandin D synthase in rat epididymidis.
    Chen DY; Liu SJ; Zhu MY; Li WY; Cui YD; Huang YF
    Anim Reprod Sci; 2007 Apr; 98(3-4):302-10. PubMed ID: 16730417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneys.
    Nagata N; Fujimori K; Okazaki I; Oda H; Eguchi N; Uehara Y; Urade Y
    FEBS J; 2009 Dec; 276(23):7146-58. PubMed ID: 19878301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands.
    Kume S; Lee YH; Miyamoto Y; Fukada H; Goto Y; Inui T
    Biochem J; 2012 Sep; 446(2):279-89. PubMed ID: 22677050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-type prostaglandin D synthase-derived PGD
    Omori K; Morikawa T; Kunita A; Nakamura T; Aritake K; Urade Y; Fukayama M; Murata T
    J Pathol; 2018 Jan; 244(1):84-96. PubMed ID: 29124765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
    Cho-Vega JH; Vega F; Schwartz MR; Prieto VG
    J Cutan Pathol; 2007 Jul; 34(7):535-42. PubMed ID: 17576332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative activation of lipocalin-type prostaglandin D synthase gene expression by activator protein-2beta in proximal promoter and upstream stimulatory factor 1 within intron 4 in human brain-derived TE671 cells.
    Fujimori K; Urade Y
    Gene; 2007 Aug; 397(1-2):143-52. PubMed ID: 17574780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ligand recognition mechanism of lipocalin-type prostaglandin D synthase].
    Shimamoto S; Yoshida T; Ohkubo T
    Yakugaku Zasshi; 2011; 131(11):1575-81. PubMed ID: 22041695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.
    Irikura D; Aritake K; Nagata N; Maruyama T; Shimamoto S; Urade Y
    J Biol Chem; 2009 Mar; 284(12):7623-30. PubMed ID: 19131342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity.
    Shimamoto S; Yoshida T; Inui T; Gohda K; Kobayashi Y; Fujimori K; Tsurumura T; Aritake K; Urade Y; Ohkubo T
    J Biol Chem; 2007 Oct; 282(43):31373-9. PubMed ID: 17715133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.